
Meditex Pharma Pvt Ltd
About Meditex Pharma Pvt Ltd
Data last updated:
Meditex Pharma Pvt Ltd is a private limited company based in Gurgaon, Haryana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 23 January 1962 and has been in existence for over 64 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24239HR1962PTC002419. Its GSTIN is 06AAECM0815A1Z7 (Haryana).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors including Kasi Vishwanathan Sundaram and Suresh Sundram.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B 232 Industrial Estate Mehrauli Road, Gurgaon, Haryana, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹58.39 Lakh, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹4.62 Lakh (net margin 7.9%) and EBITDA of ₹11.14 Lakh (EBITDA margin 19.1%). Revenue has declined at a compounded annual rate (CAGR) of 39% over three years and 14% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Meditex Pharma Pvt Ltd's registered office is in Gurgaon Haryana, Haryana. Its e-mail address is in the company report.
- Email
- Registered AddressB 232 Industrial Estate Mehrauli Road, Gurgaon, Haryana, India
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Meditex Pharma Pvt Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Meditex Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 47 | Retail trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Meditex Pharma Pvt Ltd, buy the company report.
Financials of Meditex Pharma Pvt Ltd
FY 2025 filings availableMeditex Pharma Pvt Ltd reported revenue of ₹58.39 Lakh (up 13% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 13% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 14%. EBITDA rose 123% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.14 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.62 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 19.1% | ||||
| Net Profit Margin | 7.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Meditex Pharma Pvt Ltd, buy the company report.
Board of directors of Meditex Pharma Pvt Ltd
Meditex Pharma has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kasi Vishwanathan Sundaram | Director | 13 May 1967 | 59 Years 5 Months | Current |
| Suresh Sundram | Director | 01 Sep 1997 | 29 Years 1 Months | Current |
| Sunil Sundaram Also directs: Torrins Anthem Private Limited, Eazy Softech Private Limited, Spring Hill Technologies Private Limited and 1 more | Director | 25 Mar 2017 | 9 Years 7 Months | Current |
| Jaya Sundaram | Director | 01 Sep 1997 | 29 Years 1 Months | Current |
Auditor
Meditex Pharma Pvt Ltd is audited by R S P H & ASSOCIATES for the financial year 2016.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R S P H & ASSOCIATES | FY 2016 | 003013N |
Shareholding
The shareholding of Meditex Pharma Pvt Ltd is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Meditex Pharma Pvt Ltd, buy the company report.
Legal cases
No court or tribunal cases involving Meditex Pharma Pvt Ltd are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Meditex Pharma Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Meditex Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAECM0815A1Z7 | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Meditex Pharma Pvt Ltd, buy the company report.
Recent activity
Meditex Pharma Pvt Ltd has 6 board changes on record since 1967: 5 appointments and 1 cessation. The latest: Sunil Sundaram ceased to be Additional Director on 30 Sep 2017.
Frequently asked questions
Meditex Pharma is an active private limited company based in Gurgaon, Haryana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 23 January 1962 (64+ years old) and is registered under CIN U24239HR1962PTC002419.
Meditex Pharma has 4 current directors:
- Kasi Vishwanathan Sundaram - Director
- Suresh Sundram - Director
- Sunil Sundaram - Director
- Jaya Sundaram - Director
The latest financial statements of Meditex Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Meditex Pharma is 06AAECM0815A1Z7, registered in Haryana.
The CIN (Corporate Identification Number) of Meditex Pharma is U24239HR1962PTC002419. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Meditex Pharma was incorporated on 23 January 1962, making it 64+ years old. It is registered with the Registrar of Companies, Haryana.
Sunil Sundaram ceased to be Additional Director on 30 Sep 2017. Sunil Sundaram was appointed as Director on 25 Mar 2017. Jaya Sundaram was appointed as Director on 01 Sep 1997. Meditex Pharma has 6 board changes on record in total.
The registered office of Meditex Pharma is at B 232 Industrial Estate Mehrauli Road, Gurgaon, Haryana, India.
Meditex Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Meditex Pharma is compliant as of 11 September 2026. The company is actively filing with the Registrar of Companies.

